Shed vs WeightWatchers (Sequence): Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

Shed beats WeightWatchers (Sequence) overall, scoring 7.8/10 vs 7.4/10. Shed is more affordable at $199/mo vs $423/mo. Choose Shed for users who want fast delivery and a streamlined compounded gl. Choose WeightWatchers (Sequence) for users who want glp-1 medication combined with the weightwatc.

A side-by-side comparison of Shed and WeightWatchers (Sequence) covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

Shed

#17 of 48

7.8/10

Newer GLP-1 provider focused on speed and simplicity — fast approvals, fast shipping, and a clean user experience at a competitive price point.

Visit Shed

WeightWatchers (Sequence)

#29 of 48

7.4/10

WeightWatchers' clinical weight management arm (acquired from Sequence). Membership is tiered: 12-month plan first month $149-$299 depending on tier, then $74/mo ongoing for months 2-12; shorter plans are higher per-month. Medication billed separately: $199/mo intro for 2 months, then $349/mo ongoing. Lineup includes Saxenda (liraglutide brand), Wegovy, Zepbound, and compounded semaglutide/tirzepatide.

Visit WeightWatchers (Sequence)

Feature	Shed	WeightWatchers (Sequence)
Our Score	7.8/10	7.4/10
Starting Price	$199/mo	$423/mo
Medication Type	Both	Both
Insurance Accepted	No	Yes
Best For	Users who want fast delivery and a streamlined compounded GLP-1 experience	Users who want GLP-1 medication combined with the WeightWatchers program and community — $74 ongoing membership (on 12-month plan, $149-$299 first month) + $349 ongoing medication = $423/mo all-in
Ranking	#17	#29

Pros & Cons Compared

Shed

Pros

+Industry-leading delivery speed — most patients receive medication within 2-3 days of enrollment
+$149/mo is competitively priced for an all-inclusive compounded program with good support
+Streamlined onboarding with no video call — approved and shipped faster than most competitors
+Clean, modern UX with real-time shipping tracking and easy provider messaging

Cons

−Compounded semaglutide and tirzepatide only — no brand-name options
−Newer company (founded 2024) with limited track record and outcome data
−No insurance billing and no FSA/HSA superbills currently available
−Clinical support is responsive but less proactive than premium platforms

WeightWatchers (Sequence)

Pros

+Combines GLP-1 medication with WeightWatchers' proven points system and community support
+Insurance accepted for medication — can reduce costs significantly with qualifying plans
+Decades of brand trust and weight loss expertise applied to clinical medication management
+Access to WW community, workshops, and digital tools alongside medication

Cons

−$269/mo without insurance is expensive for what's included clinically
−The WW program integration adds complexity that medication-only users won't value
−The Sequence acquisition is still integrating — some operational inconsistencies remain
−Less medication flexibility than pure-play GLP-1 platforms

Our Verdict

Shed edges out WeightWatchers (Sequence) with a score of 7.8/10 vs 7.4/10. If budget is your priority, Shed starts at $199/mo compared to WeightWatchers (Sequence)'s $423/mo. WeightWatchers (Sequence) accepts insurance, which can significantly reduce your out-of-pocket costs. Choose Shed if you want: users who want fast delivery and a streamlined compounded glp-1 experience. Choose WeightWatchers (Sequence) if you want: users who want glp-1 medication combined with the weightwatchers program and community — $74 ongoing membership (on 12-month plan, $149-$299 first month) + $349 ongoing medication = $423/mo all-in.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Shed nor WeightWatchers (Sequence) feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review